Access cutting-edge lung transplant failure and rejection treatment through this clinical trial at a research site in Columbus. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Columbus location
Preparing your pre-screening questions…
Access lung transplant failure and rejection specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lung transplant failure and rejection treatment provided free
Check if you qualify for this lung transplant failure and rejection clinical trial in Columbus, OH
No-Cost Study Care
Local to Columbus
Convenient for OH residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study is for people who have had a lung transplant and developed a condition called chronic lung allograft dysfunction (CLAD), which is a type of chronic rejection. Doctors often treat CLAD with a procedure called extracorporeal photopheresis (ECP), but it can take up to six months to know if the treatment is working. The goal of the study is to find early signs (biomarkers) that show whether ECP is helping, so patients can get the right care sooner. For participants in the study, small blood samples will be collected at three points during ECP treatment and, for some participants, two MRI scans of the lungs will be performed-one before starting ECP and one after finishing treatment. The MRI uses a safe contrast dye to help us see changes in lung blood flow and tissue. Investigators will also look at certain immune cells in the blood. This is not a study of a new drug or treatment-participants will receive the same ECP therapy their doctor already recommended. The study will help researchers understand how ECP works and identify markers that predict who benefits most. There is no direct benefit to participants, but participation may help improve care for future lung transplant patients.
Sponsor: Brian Keller
Yes, this clinical trial (NCT07434869) has an active research site in Columbus, OH that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for lung transplant failure and rejection treatment options in Columbus, OH, this clinical trial (NCT07434869) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Columbus research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung transplant failure and rejection specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all lung transplant failure and rejection clinical trials near you to find additional studies recruiting in your area.
See all rheumatoid arthritis clinical trials recruiting in Columbus — not just this study.
Browse Rheumatoid Arthritis Trials in Columbus →